Sign in

CIK 0001851484 · <br>Emerging growth company

CITIUS ONCOLOGY, INC.

Sign in to watch
Ticker
CTOR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
DE
Entity type
operating
EIN
994362660
Phone
(908) 967-6677
Business address
11 COMMERCE DRIVE, 1ST FLOOR, CRANFORD, NJ, 07016
Former names
TenX Keane Acquisition
  1. 424B5 Offering Prospectus
  2. 8-K Event Regulation FD disclosure · Other events
  3. 4/A Grant or award Director acquired 300,000 shares (grant or award)
  4. 4/A Grant or award Director acquired 300,000 shares (grant or award)
  5. 4/A Grant or award Director acquired 300,000 shares (grant or award)
  6. 4/A Grant or award Director acquired 300,000 shares (grant or award)
  7. 4/A Grant or award Chief Financial Officer acquired 825,000 shares (grant or award)
  8. 4/A Grant or award Secretary acquired 850,000 shares (grant or award)
  9. 4/A Grant or award Director acquired 300,000 shares (grant or award)
  10. 4/A Grant or award Director acquired 300,000 shares (grant or award)
  11. 4/A Grant or award Chief Executive Officer acquired 1,700,000 shares (grant or award)
  12. 4/A Grant or award Chief Medical Officer acquired 825,000 shares (grant or award)
  13. SCHEDULE 13G Stake Statement of Beneficial Ownership
  14. 8-K Event Executive or director change · Shareholder vote results
  15. 8-K Event Regulation FD disclosure
  16. DEF 14A Proxy Proxy Statement
  17. 4 Grant or award Secretary acquired 950,000 shares (grant or award)
  18. 4 Grant or award Director acquired 300,000 shares (grant or award)
  19. 4 Grant or award Chief Executive Officer acquired 1,700,000 shares (grant or award)
  20. 4 Grant or award Director acquired 300,000 shares (grant or award)

Page 4 of 14 · 268 filings